AC Immune Reports Full Year 2023 Financial Results and Provides a Corporate UpdateGlobe Newswire • about 2 months agoAC Immune Reports Full Year 2023 Financial Results and Provides a Corporate Update ACI-24.060 ABATE Phase 2 trial to report Abeta-PET imaging results in Q2 and H2ACI-7104.056 VacSYn Phase 2 trial in...